￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of feasibility and potential risks of long-term use of DaliRasen (Keweike)

2026-02-01 22:25:32

Check Details
Contraindications and unsuitable groups for Lynparza

2026-02-01 22:25:32

Check Details
Detailed explanation of reimbursement scope and reimbursement conditions for Venetoclax

2026-02-01 22:25:32

Check Details
The launch time and approval progress of Asciminib in China

2026-02-01 22:25:32

Check Details
Analysis of the efficacy and safety of the second phase clinical trial of ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Efficacy and clinical data analysis of sparsentan (sparsentan) in the treatment of IgA nephropathy

2026-02-01 22:25:32

Check Details
Which diseases can Ixazomib (Enleri) be used to treat and its efficacy evaluation?

2026-02-01 22:25:32

Check Details
Analysis of domestic prices and reference costs of Lurbinectedin in 2025

2026-02-01 22:25:32

Check Details
What are the common side effects of furmonertinib, their occurrence time and countermeasures?

2026-02-01 22:25:32

Check Details
Correct usage and safety instructions for taking ensifentrine-Ohtuvayre

2026-02-01 22:25:32

Check Details
What you need to know about the effects, potential hazards and risk prevention of Roaccutane (isotretinoin) soft capsules

2026-02-01 22:25:32

Check Details
What is doxorubicin? Introduction to antitumor drug classification and clinical application

2026-02-01 22:25:32

Check Details
Category
相关知识